Karnofsky performance status and visual analogue scale scores are simple indicators for quality of life in long-term AYA survivors who received allogeneic hematopoietic stem cells transplantation in childhood

被引:17
作者
Ishida, Yasushi [1 ]
Kamibeppu, Kiyoko [2 ]
Sato, Atsushi [3 ]
Inoue, Masami [4 ]
Hayakawa, Akira [5 ]
Shiobara, Masaaki [6 ]
Yabe, Hiromasa [7 ]
Koike, Kazutoshi [8 ]
Adachi, Soichi [9 ]
Yamashita, Takuya [10 ]
Kanda, Yoshinobu [11 ]
Okamoto, Shinichiro [12 ]
Atsuta, Yoshiko [13 ,14 ]
机构
[1] Ehime Prefectural Cent Hosp, Pediat Med Ctr, 83 Kasuga Machi, Matsuyama, Ehime 7900024, Japan
[2] Univ Tokyo, Div Hlth Sci & Nursing, Grad Sch Med, Dept Family Nursing, Tokyo, Japan
[3] Miyagi Childrens Hosp, Dept Hematol & Oncol, Sendai, Miyagi, Japan
[4] Osaka Womens & Childrens Hosp, Dept Hematol Oncol, Osaka, Japan
[5] Yodogawa Christians Hosp, Dept Palliat Care Med, Osaka, Japan
[6] Shiobara Clin, Nagano, Japan
[7] Tokai Univ, Dept Innovat Med Sci, Sch Med, Isehara, Kanagawa, Japan
[8] Ibaraki Childrens Hosp, Dept Hematol & Oncol, Mito, Ibaraki, Japan
[9] Kyoto Univ, Dept Human Hlth Sci, Sch Med, Kyoto, Japan
[10] St Lukes Int Hosp, Dept Hematol, Tokyo, Japan
[11] Jichi Med Univ, Div Hematol, Shimotsuke, Tochigi, Japan
[12] Keio Univ, Dept Med, Div Hematol, Sch Med, Tokyo, Japan
[13] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan
[14] Aichi Med Univ, Dept Registry Sci Transplant & Cellular Therapy, Sch Med, Nagakute, Aichi, Japan
关键词
Karnofsky scores; VAS scores; QOL; Survivors; Allogeneic hematopoietic stem cells transplantation; MULTIPLE-MYELOMA; RECIPIENTS; REMISSION; VARIABLES; OUTCOMES; IMPACT; BMT;
D O I
10.1007/s12185-022-03426-5
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
The purpose of this study was to investigate Karnofsky performance status (KPS) scores and visual analogue scale (VAS) scores to explain which domains in the standardized self-reported quality of life (QOL) are instrumental for long-term hematopoietic stem cell transplantation (HSCT) survivors. We conducted a nationwide cross-sectional questionnaire study on 221 survivors with allogeneic-HSCT in 28 pediatric centers. Patient-reported QOL was assessed at a single time point using the 36-item Short-Form Survey (SF-36), the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT), and VAS scores. KPS scores were significantly correlated with both physical and role component summary scores of the SF-36, while the VAS provided by the patient (VASpt) was significantly correlated with the mental component summary score of the SF-36 and many subscales of the FACT-BMT. The VAS provided by the participants' attending physician (VASdoc) was correlated well with KPS scores. A VASpt score more than 40% lower than KPS scores suggested mental health problems. In conclusion, KPS scores might be considered as an indicator for physical and role/social components and VASpt score as an indicator for mental components and HSCT-specific QOL.
引用
收藏
页码:787 / 797
页数:11
相关论文
共 27 条
[2]
Longitudinal health-related quality of life outcomes and related factors after pediatric SCT [J].
Barrera, M. ;
Atenafu, E. ;
Hancock, K. .
BONE MARROW TRANSPLANTATION, 2009, 44 (04) :249-256
[3]
A French Cohort of Childhood Leukemia Survivors: Impact of Hematopoietic Stem Cell Transplantation on Health Status and Quality of Life [J].
Berbis, Julie ;
Michel, Gerard ;
Chastagner, Pascal ;
Sirvent, Nicolas ;
Demeocq, Francois ;
Plantaz, Dominique ;
Barlogis, Vincent ;
Contet, Audrey ;
Poiree, Marilyne ;
Kanold, Justyna ;
Galambrun, Claire ;
Baumstarck, Karine ;
Chambost, Herve ;
Auquier, Pascal .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (07) :1065-1072
[4]
Health-Related quality of life (HRQoL): The Impact of Medical and Demographic Variables Upon Pediatric Recipients of Hematopoietic Stem Cell Transplantation [J].
Brice, Lisa ;
Weiss, Rebecca ;
Wei, Ying ;
Satwani, Prakash ;
Bhatia, Monica ;
George, Diane ;
Garvin, James ;
Morris, Erin ;
Harrison, Lauren ;
Cairo, Mitchell S. ;
Sands, Stephen A. .
PEDIATRIC BLOOD & CANCER, 2011, 57 (07) :1179-1185
[5]
Quality of life in 244 recipients of allogeneic bone marrow transplantation [J].
Chiodi, S ;
Spinelli, S ;
Ravera, G ;
Petti, AR ;
van Lint, MT ;
Lamparelli, T ;
Gualandi, F ;
Occhini, D ;
Mordini, N ;
Berisso, G ;
Bregante, S ;
Frassoni, F ;
Bacigalupo, A .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (03) :614-619
[6]
Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report [J].
Chow, Eric J. ;
Anderson, Lynnette ;
Baker, K. Scott ;
Bhatia, Smita ;
Guilcher, Gregory M. T. ;
Huang, Jennifer T. ;
Pelletier, Wendy ;
Perkins, Joanna L. ;
Rivard, Linda S. ;
Schechter, Tal ;
Shah, Ami J. ;
Wilson, Karla D. ;
Wong, Kenneth ;
Grewal, Satkiran S. ;
Armenian, Saro H. ;
Meacham, Lillian R. ;
Mulrooney, Daniel A. ;
Castellino, Sharon M. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (05) :782-795
[7]
Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer [J].
Denis, Fabrice ;
Basch, Ethan ;
Septans, Anne-Lise ;
Bennouna, Jaafar ;
Urban, Thierry ;
Dueck, Amylou C. ;
Letellier, Christophe .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (03) :306-307
[8]
Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation [J].
Fenske, Timothy S. ;
Ahn, Kwang W. ;
Graff, Tara M. ;
DiGilio, Alyssa ;
Bashir, Qaiser ;
Kamble, Rammurti T. ;
Ayala, Ernesto ;
Bacher, Ulrike ;
Brammer, Jonathan E. ;
Cairo, Mitchell ;
Chen, Andy ;
Chen, Yi-Bin ;
Chhabra, Saurabh ;
D'Souza, Anita ;
Farooq, Umar ;
Freytes, Cesar ;
Ganguly, Siddhartha ;
Hertzberg, Mark ;
Inwards, David ;
Jaglowski, Samantha ;
Kharfan-Dabaja, Mohamed A. ;
Lazarus, Hillard M. ;
Nathan, Sunita ;
Pawarode, Attaphol ;
Perales, Miguel-Angel ;
Reddy, Nishitha ;
Seo, Sachiko ;
Sureda, Anna ;
Smith, Sonali M. ;
Hamadani, Mehdi .
BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (02) :235-248
[9]
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report [J].
Filipovich, AH ;
Weisdorf, D ;
Pavletic, S ;
Socie, G ;
Wingard, JR ;
Lee, SJ ;
Martin, P ;
Chien, J ;
Przepiorka, D ;
Couriel, D ;
Cowen, EW ;
Dinndorf, P ;
Farrell, A ;
Hartzman, R ;
Henslee-Downey, J ;
Jacobsohn, D ;
McDonald, G ;
Mittleman, B ;
Rizzo, JD ;
Robinson, M ;
Schubert, M ;
Schultz, K ;
Shulman, H ;
Turner, M ;
Vogelsang, G ;
Flowers, MED .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (12) :945-956
[10]
Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan [J].
Fukuhara, S ;
Bito, S ;
Green, J ;
Hsiao, A ;
Kurokawa, K .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) :1037-1044